Detailed Narrative
Q3 FY26 Performance and Inventory Challenges
Kirloskar Pneumatic reported Q3 FY26 sales of INR 403.5 crores, an 18.5% increase year-over-year. However, the company internally met most manufacturing targets but could not translate them into sales due to large packages not being cleared for dispatch by customers, leading to higher inventory. Management expects these packages to be cleared in Q4 FY26, specifically by February, which would have added over INR 150 crores to Q3 sales.
Robust Order Book and Shift in Composition
As of January 1, 2026, the company's order book stood at INR 1,939 crores, marking a 19% growth compared to INR 1,624 crores at the beginning of the previous year. Notably, the current order book has no large package orders, unlike the previous year which included INR 600 crores of such orders. This shift towards non-traditional, smaller orders is expected to result in smoother quarter-on-quarter sales execution in the next fiscal year.
Product Line Developments and Capacity Expansion
The air compressor business had a steady quarter, with the Tezcatlipoca centrifugal compressor continuing to perform well. The company invested in new CNC machines from Japan and Germany to double capacity in this line, with additional capacity available from Q1 FY27. In refrigeration, two Zephyros plants were commissioned as technology demonstrators, and the company expects PLI program clearance this quarter for bulk manufacturing. Sales of the Khione package and Tyche semi-hermetic compressor are scaling up.
Strategic Focus on Ammonia-Based Refrigeration (Zephyros)
Kirloskar Pneumatic is developing Zephyros, an ammonia-based refrigeration system utilizing patented zero-GWP refrigerant technologies. This system is positioned as environmentally friendly, economically cheaper, and more efficient than standard refrigerants. The company aims to capture significant market share in the commercial chilled water segment, potentially worth up to INR 5,000 crores, and is pursuing PLI approval to scale up volumes.
Capital Allocation and Financial Health
The company maintained its debt-free status with a net cash position of INR 395 crores as of January 1, 2026. YTD FY26 capex spend was INR 54 crores, with a full-year expectation of INR 90 crores. An interim dividend of INR 3.50 per share (175% on face value of INR 2) was approved. The company also anticipates an additional capex of INR 200 crores over the next 1-1.5 years for PLI-related manufacturing, which is expected to generate sales five times the investment.
Outlook and Margin Management
For FY26, the company projects sales between INR 1,800-1,850 crores and PBT between INR 345-360 crores, representing a 12-14% top-line growth and over 20% bottom-line growth. Management targets a 20% EBIT margin and expects to return to a 20% top-line growth rate from FY27 onwards. The raw material to sales ratio improved by 3.7% in Q3 FY26, and the company aims to further reduce it by 1-2% through enhanced manufacturing capabilities and strategic order selection.
Leadership Transition and Employee Engagement
The company is undergoing a planned leadership transition with Mr. Aman appointed as the new MD, following Mr. K. Srinivasan's 5-year tenure focused on succession planning. Management highlighted strong employee engagement scores (86, above industry average of 82-83) and low attrition rates (below 10%), alongside a high rate of IP filing (over 40 per year), indicating a robust internal environment for future growth.